Thermo Fisher stock dips today as Wall Street sizes up next week’s earnings
23 January 2026
1 min read

Thermo Fisher stock dips today as Wall Street sizes up next week’s earnings

New York, Jan 23, 2026, 11:08 EST — Regular session

  • Shares of Thermo Fisher slipped roughly 1.2% in late morning trading, snapping a two-day winning streak
  • Investors turn their attention to the Jan. 29 results and insights on 2026 demand
  • Shares of life-science tools peers are also down

Shares of Thermo Fisher Scientific dipped on Friday as investors pared back their holdings ahead of the company’s quarterly earnings release next week, following gains earlier in the week.

The laboratory equipment and services sector often signals biotech and pharma spending patterns. With earnings just around the corner, traders are adjusting expectations for any change in management’s outlook on order trends, pricing, and margins.

Thermo Fisher shares slipped roughly 1.2% to $631.70 in late morning trading, following Thursday’s close at $639.45.

Thermo Fisher’s shares climbed about 3% since closing on Jan. 20, tightening the margin for mistakes ahead of earnings.

Thermo Fisher plans to report its fourth-quarter and full-year 2025 earnings before markets open on Thursday, Jan. 29. The company will follow up with a conference call at 8:30 a.m. ET.

A minor corporate filing caught investors’ attention this week. Dated Jan. 21, a Form 25-NSE details the removal from listing and registration of securities that have matured, been redeemed, or retired — a step linked to debt securities, not the company’s common stock.

Peers dragged the group lower as well. Danaher dropped around 1.6%, and Agilent Technologies slipped close to 1.7%. The Health Care Select Sector SPDR ETF lost about 0.5%.

According to Zacks, Wall Street anticipates earnings growth when Thermo Fisher reports next week, raising the stakes on any earnings shortfall or conservative guidance.

Investors are zeroing in on segment-level cues, especially specialty diagnostics, where forecasts expect steady demand instead of a quick bounce back.

But the setup can backfire. If management flags weaker customer spending, shrinking research budgets, or uneven instrument demand, a stock that’s already climbed ahead of the earnings report can quickly lose ground.

Thermo Fisher’s next big moment hits Thursday with its report and the 8:30 a.m. ET call on Jan. 29. Investors will be focused on guidance and order updates, which should set the tone for TMO shares going forward.

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors. Follow Khadija Saeed on Google News.

Stock Market Today

  • ASML Shares Slide 6% on China DUV News; Analysts Cite 'Overdone' Reaction
    July 27, 2026, 6:54 PM EDT. Shares in ASML Holding (ASML) declined 6% following news that China has started making its own immersion deep ultraviolet (DUV) lithography machines. Analysts at JPMorgan and P Equity Research described the market response as excessive, highlighting that China's output is minimal in comparison to the 131 units delivered by ASML last year. China's technology is still in its infancy and lags behind ASML's systems. The company's EUV machines are still subject to U.S. export bans affecting sales to China.
British American Tobacco share price in focus before London open after buyback disclosure
Previous Story

British American Tobacco share price in focus before London open after buyback disclosure

Exxon stock price: XTO’s Eagle Ford sale push puts XOM in play ahead of key week
Next Story

Exxon stock price: XTO’s Eagle Ford sale push puts XOM in play ahead of key week